HYPERPOLARIZED 3HE MRI OF MURINE LUNG FUNCTION

小鼠肺功能的超极化 3HE MRI

基本信息

  • 批准号:
    7956892
  • 负责人:
  • 金额:
    $ 2.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-07-01 至 2010-06-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Project is part of a contract project with Merck Frosst Centre for Respiratory Imaging, Robarts Research Institute, Ontario, Canada The primary aim is to clearly demonstrate the ability of 3He imaging to differentiate the airway hyper-responsiveness phenotype in several mouse models of asthma as specified by Merck. Various image analysis and quantification paradigms will be tested. An initial aim is to integrate Merck's specialized 3He ventilator with the imaging. The project is thus broken down into three stages and associated milestones. --Stage I is to test the performance of the Merck ventilator against the Duke ventilator for hyperpolarized 3He delivery and imaging. -- Simultaneously, the Merck asthma model will be implemented and evaluated at Duke by Dr. Mike Foster. -- Once a suitable ventilator is chosen, Stage II will employ 3He imaging to test differences in AHR between an OVA/PBS mouse and an OVA/OVA mouse.
这个子项目是众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ben D. Chen其他文献

UTL-5g Lowers Elevated Blood Levels of TNF-a and TGF-? and Increases Survival Rates in Animals Treated with LPS/D-(+)-galactosamine
UTL-5g 降低血液中升高的 TNF-a 和 TGF- 水平?
  • DOI:
    10.5099/aj140200128
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yiguan Zhang;Yongxing Tang;Ben D. Chen;F. Valeriote;Xiaohui Li;J. Shaw
  • 通讯作者:
    J. Shaw
The Active Metabolite of UTL-5g, 5-Methylisoxazole-3-Carboxylic Acid, is Anti-Inflammatory and Reduces Doxorubicin-Induced Cardiac Toxicity
UTL-5g 的活性代谢物 5-甲基异恶唑-3-羧酸具有抗炎作用并减少阿霉素引起的心脏毒性
  • DOI:
    10.5099/aj160300228
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yiguan Zhang;Yongxing Tang;Ben D. Chen;F. Valeriote;S. Gautam;Xiaohua Gao;J. Shaw
  • 通讯作者:
    J. Shaw
A Novel Leflunomide Analog, UTL-5b (GBL-5b), Suppresses JAK3, MAP3K2, and LITAF Genes
新型来氟米特类似物 UTL-5b (GBL-5b),抑制 JAK3、MAP3K2 和 LITAF 基因
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    J. Shaw;Ben D. Chen;P. Wooley;B. Palfey;A. Lee;Wen‐Hsin Huang;Dustin Zeng
  • 通讯作者:
    Dustin Zeng
HPLC Plasma Assay of a Novel Anti-MRSA Compound, Kaempferol-3-O-Alpha-L-(2″,3″-di-p-coumaroyl)rhamnoside, from Sycamore Leaves
对来自梧桐叶的新型抗 MRSA 化合物 Kaempferol-3-O-Alpha-L-(2″,3″-di-p-coumaroyl)rhamnoside 进行 HPLC 血浆测定
  • DOI:
    10.1177/1934578x1501000818
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    1.8
  • 作者:
    Yiguan Zhang;F. Valeriote;K. Swartz;Ben D. Chen;M. Hamann;Douglas L. Rodenburg;J. McChesney;J. Shaw
  • 通讯作者:
    J. Shaw
Identification of the Metabolites of a Novel Anti-MRSA Compound, Kaempferol-3-O-Alpha-L-(2″,3″-di-p-coumaroyl)rhamnoside (KCR), Extracted from American Sycamore
从美国梧桐中提取的新型抗 MRSA 化合物 Kaempferol-3-O-Alpha-L-(2″,3″-di-p-coumaroyl)rhamnoside (KCR) 代谢物的鉴定
  • DOI:
    10.1177/1934578x1801300321
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    1.8
  • 作者:
    J. Shaw;K. Swartz;F. Valeriote;J. Media;Ben D. Chen;M. Hamann;Xiaojuan Wang
  • 通讯作者:
    Xiaojuan Wang

Ben D. Chen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ben D. Chen', 18)}}的其他基金

Novel Compounds from Sycamore Leaves for the Treatment of MRSA
来自梧桐叶的新型化合物可用于治疗 MRSA
  • 批准号:
    9184905
  • 财政年份:
    2015
  • 资助金额:
    $ 2.18万
  • 项目类别:
GM-CSF RECEPTOR/LYN INTERACTION AND MYELOID LEUKEMIAS
GM-CSF 受体/LYN 相互作用与粒细胞白血病
  • 批准号:
    6172868
  • 财政年份:
    1987
  • 资助金额:
    $ 2.18万
  • 项目类别:

相似海外基金

Enhancing Wahkohtowin (Kinship beyond the immediate family) Community-based models of care to reach and support Indigenous and racialized women of reproductive age and pregnant women in Canada for the prevention of congenital syphilis
加强 Wahkohtowin(直系亲属以外的亲属关系)以社区为基础的护理模式,以接触和支持加拿大的土著和种族育龄妇女以及孕妇,预防先天梅毒
  • 批准号:
    502786
  • 财政年份:
    2024
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Directed Grant
Digging Deeper with AI: Canada-UK-US Partnership for Next-generation Plant Root Anatomy Segmentation
利用人工智能进行更深入的挖掘:加拿大、英国、美国合作开发下一代植物根部解剖分割
  • 批准号:
    BB/Y513908/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Research Grant
Establishment of new UK/Canada Collaboration towards the Advancement of Magnetic Particle Imaging (MPI)
英国/加拿大建立新的合作关系以推动磁粒子成像 (MPI) 的发展
  • 批准号:
    MR/Y033795/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Research Grant
The Implementation of Sustainable Wine Tourism in Japan and Canada
日本和加拿大可持续葡萄酒旅游的实施
  • 批准号:
    24K21017
  • 财政年份:
    2024
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Cryptosporidium Artificial Intelligence Network Analysis of Drug Action (CANADA)
隐孢子虫药物作用人工智能网络分析(加拿大)
  • 批准号:
    EP/Z532885/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Research Grant
Towards the eradication of congenital syphilis in Canada
努力在加拿大根除先天性梅毒
  • 批准号:
    502787
  • 财政年份:
    2024
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Directed Grant
Skin Investigation Network of Canada (SkIN Canada): Advancing interdisciplinary, patient-relevant research to improve skin health
加拿大皮肤调查网络 (SkIN Canada):推进跨学科、与患者相关的研究,以改善皮肤健康
  • 批准号:
    481682
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Operating Grants
Improving pregnancy and reproductive health of people experiencing incarceration in Canada by mobilizing knowledge with community partners
通过与社区合作伙伴调动知识,改善加拿大被监禁者的怀孕和生殖健康
  • 批准号:
    476891
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
Partnering For Pain: Identifying and actioning the Top 10 priorities for pediatric chronic pain in Canada
携手应对疼痛:确定加拿大儿科慢性疼痛的十大优先事项并采取行动
  • 批准号:
    485109
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Operating Grants
Network for Integrated Care Excellence (NICE) Canada: Transforming Health with Integrated Care Knowledge Mobilization and Impact Hub
加拿大卓越综合护理网络 (NICE):通过综合护理知识动员和影响力中心改变健康状况
  • 批准号:
    485405
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了